Health Care: Drugs

Dr Reddy Laboratories Ltd (RDY: NYSE)

$43.11 0.36 | 0.84%
04/23/14 - 04:03 PM ET
Company Income Statement
Mar 2013 Mar 2012 Mar 2011 Mar 2010
Sales 2.14B 1.90B 1.67B 1.56B
Cost of Sales 921.54M 751.34M 678.32M 661.64M
Gross Operating Profit 1.22B 1.15B 994.81M 899.91M
Selling, General, and Administrative Expenses 617.27M 567.49M 530.63M 500.06M
Research & Development 141.05M 116.20M 113.34M 84.28M
Operating Income before D & A (EBITDA) 457.11M 466.70M 350.83M 315.57M
Depreciation & Amortization 101.99M 102.48M 92.92M 92.44M
Interest Income 27.17M 24.12M 3.88M 8.20M
Other Income - Net 0.00 15.04M 24.98M 13.71M
Special Income / Charges 32.92M -20.45M 0.00 -191.16M
Total Income Before Interest Expenses (EBIT) 417.12M 383.99M 286.83M 53.88M
Interest Expense 18.71M 20.98M 8.11M 8.27M
Pre-Tax Income 398.40M 363.02M 278.72M 45.62M
Income Taxes 90.06M 82.65M 31.43M 21.89M
Minority Interest -18.38K 0.00 0.00 0.00
Net Income From Continuing Operations 308.34M 280.37M 247.30M 23.73M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 308.34M 280.37M 247.30M 23.73M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 308.36M 280.37M 247.30M 23.73M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
275.42M 300.82M 247.30M 214.89M
Preferred Dividends
Net Income Available To Common 308.34M 280.37M 247.30M 23.73M
Basic EPS from Continuing Ops. 1.82 1.65 1.46 0.14
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.82 1.65 1.46 0.14
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.82 1.65 1.46 0.14
Basic Normalized Net Income/Share 1.62 1.78 1.46 1.27
EPS fr Continuing Ops. 1.81 1.65 1.45 0.14
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.81 1.65 1.45 0.14
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.81 1.65 1.45 0.14
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.62 1.77 1.45 1.27
Dividends Paid per Share 0.23 0.23 0.22 0.11

Portfolios with RDY

Latest RDY Headlines from TheStreet

More Financial News for RDY

Press Releases for RDY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter